Diabetes and Bladder Cancer

Pioglitazone Is Associated with Excess Risk for Bladder Cancer Using pioglitazone for >2 years or exceeding a cumulative dose of 28,000 mg imparted the highest risk. In 2011, the FDA issued a safety warning for […]